Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 128Brain Neoplasms 114Prostatic Neoplasms 101Neoplasm Metastasis 83Lung Neoplasms 71Carcinoma, Hepatocellular 71Pancreatic Neoplasms 67Breast Neoplasms 47Melanoma 44Carcinoma, Renal Cell 36Neoplasms 33Colorectal Neoplasms 26Squamous Cell Carcinoma of Head and Neck 25Glioblastoma 24Liver Neoplasms 20Head and Neck Neoplasms 16Small Cell Lung Carcinoma 15Sarcoma 13Glioma 12Kidney Neoplasms 11Urinary Bladder Neoplasms 9Recurrence 9Gliosarcoma 8Ovarian Neoplasms 7Adenocarcinoma of Lung 7Adenocarcinoma 7Prostate Cancer Metastatic 6Cholangiocarcinoma 6Central Nervous System Neoplasms 6Uveal Melanoma 5

Interventions

selinexor 1pembrolizumab 1apalutamide 1Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Castration Levels of Testosterone × Radiosurgery × Clear all
NCT03503344 2026-01-21

PILLAR

University of California, San Francisco

Phase 2 Completed
26 enrolled 11 charts
Genitourinary

Castration Levels of Testosterone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡